Freenome

Decision/Risk Analysis · Brisbane, CA · Founded 2014 · Privately Held (backing)

Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. Freenome is based in Brisbane, CA and was founded in 2014. It is valued at about $2.2 billion as of Oct 2026, set by institutional fund marks. It has raised $1.4 billion across 3 recorded rounds; the latest was a $240 million pipe round in Dec 2025.

PMV mark · valuation
$2.2B
Oct 2026
Priced at
—
Total raised
$1.4B
Last round
PIPE
Dec 2025
What is Freenome worth?
$2.2BPrivateMarketView mark · Oct 2026

Reported valuation; nothing comparable since.

Pro
The prices on Freenome
  • ·29 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Freenome funding history

3 rounds
DateRoundRaisedPost-money
Dec 2025PIPE$240.0M▮
Feb 2024Later Stage VC (Series F)$254.0M▮
Dec 2021Later Stage VC (Series D)$300.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Freenome valuation

Freenome is valued at approximately $2.2 billion as of Oct 2026. The figure is set by institutional fund marks.

Recent activity

In the last 90 days, Freenome's record added 3 institutional fund marks (latest period Jul 2026).

How much has Freenome raised?

Freenome has raised $1.4 billion across 3 recorded rounds since 2021. The largest was a $300 million Series D in Dec 2021; the most recent was a $240 million pipe round in Dec 2025.

Institutional holders and vehicles

4 SEC-registered funds reported 29 fair-value marks on Freenome between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

Comparable companies

Comparable decision/risk analysis names by valuation on PrivateMarketView: HeartFlow (NAS: HTFL) ($1.5 billion), Anumana ($580 million) and VideaHealth ($400 million).

How Freenome's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Freenome, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →

Frequently asked about Freenome

What is Freenome worth?
Freenome is valued at $2.2B as of Oct 2026. Reported valuation; nothing comparable since.
How much has Freenome raised?
Freenome has raised $1.4B in total funding across 3 recorded rounds.
When did Freenome last raise?
Freenome last raised in Dec 2025 (PIPE), raising $240.0M.